研究单位：[1]Taizhou Hanzhong biomedical co. LTD[2]Union Hospital Affiliated to Tongji Medical College, Huazhong University of science and technology,Wuhan,Hubei,China,430022[3]Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology,Wuhan,Hubei,China,430030[4]Hunan Cancer Hospital,Changsha,Hunan,China,410000[5]Fudan University Shanghai Cancer Center,Shanghai,Shanghai,China,200032[6]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Sichuan,China,400016
研究目的：
This is a single-arm, multicenter study to evaluate the efficacy and safety of HX008 injection in patients with BCG-unresponsive non-muscle invasive bladder cancer.
